Reiko Matsuzawa
Nagoya, 4660065, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Five-year prognostic impact of pre-existing interstitial lung disease in non-small cell lung cancer patients treated with anti-PD-1 monotherapy: a retrospective analysis.
Journal: BMC cancer
Published: February 01, 2026
Favorable clinical impact of histological subtype with non-small cell carcinoma-not otherwise specified in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Journal: Respiratory investigation
Published: May 30, 2025
Clinical benefit of PD-1/PD-L1 inhibitors for poor performance status patients with advanced non-small cell lung cancer.
Journal: Journal of chemotherapy (Florence, Italy)
Published: March 25, 2025
Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer.
Journal: BMC cancer
Published: July 13, 2024
Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report.
Journal: Case reports in oncology
Published: May 23, 2024
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review.
Journal: Frontiers in oncology
Published: April 17, 2024
Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis.
Journal: BMC cancer
Published: December 17, 2023
The Application of Mixed Reality in Bronchoscopy Simulation Training: A Feasibility Study.
Journal: Surgical innovation
Published: March 01, 2023
Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR.
Journal: Journal of cancer research and clinical oncology
Published: July 11, 2022
A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 09, 2021
Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: August 26, 2021
Last Updated: 09/26/2026